Global Contraceptive Drugs and Devices Market Growth 2025-2031
The global Contraceptive Drugs and Devices market size is predicted to grow from US$ 7239 million in 2025 to US$ 9474 million in 2031; it is expected to grow at a CAGR of 4.6% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A contraceptive is a device or drug that prevents a woman from becoming pregnant.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Contraceptive Drugs and Devices Industry Forecast” looks at past sales and reviews total world Contraceptive Drugs and Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Contraceptive Drugs and Devices sales for 2025 through 2031. With Contraceptive Drugs and Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contraceptive Drugs and Devices industry.
This Insight Report provides a comprehensive analysis of the global Contraceptive Drugs and Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Contraceptive Drugs and Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Contraceptive Drugs and Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contraceptive Drugs and Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contraceptive Drugs and Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Contraceptive Drugs and Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Contraceptive Drugs and Devices market?
What factors are driving Contraceptive Drugs and Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Contraceptive Drugs and Devices market opportunities vary by end market size?
How does Contraceptive Drugs and Devices break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A contraceptive is a device or drug that prevents a woman from becoming pregnant.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Contraceptive Drugs and Devices Industry Forecast” looks at past sales and reviews total world Contraceptive Drugs and Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Contraceptive Drugs and Devices sales for 2025 through 2031. With Contraceptive Drugs and Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contraceptive Drugs and Devices industry.
This Insight Report provides a comprehensive analysis of the global Contraceptive Drugs and Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Contraceptive Drugs and Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Contraceptive Drugs and Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contraceptive Drugs and Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contraceptive Drugs and Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Contraceptive Drugs and Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Oral
- Vaginal
- Injectable Contraceptive Drugs
- Male/Female Contraceptive Devices
- Hospitals
- Pharmacies
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer Healthcare
- Merck
- Church & Dwight
- Warmer Chilcott
- Agile Therapeutics
- Pfizer
- BioSante Pharmaceuticals
- Mayer Laboratories
- Pantarhei Bioscience
- Teva Pharmaceutical Industries
What is the 10-year outlook for the global Contraceptive Drugs and Devices market?
What factors are driving Contraceptive Drugs and Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Contraceptive Drugs and Devices market opportunities vary by end market size?
How does Contraceptive Drugs and Devices break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Contraceptive Drugs and Devices Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Contraceptive Drugs and Devices by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Contraceptive Drugs and Devices by Country/Region, 2020, 2024 & 2031
2.2 Contraceptive Drugs and Devices Segment by Type
2.2.1 Oral
2.2.2 Vaginal
2.2.3 Injectable Contraceptive Drugs
2.2.4 Male/Female Contraceptive Devices
2.3 Contraceptive Drugs and Devices Sales by Type
2.3.1 Global Contraceptive Drugs and Devices Sales Market Share by Type (2020-2025)
2.3.2 Global Contraceptive Drugs and Devices Revenue and Market Share by Type (2020-2025)
2.3.3 Global Contraceptive Drugs and Devices Sale Price by Type (2020-2025)
2.4 Contraceptive Drugs and Devices Segment by Application
2.4.1 Hospitals
2.4.2 Pharmacies
2.4.3 Others
2.5 Contraceptive Drugs and Devices Sales by Application
2.5.1 Global Contraceptive Drugs and Devices Sale Market Share by Application (2020-2025)
2.5.2 Global Contraceptive Drugs and Devices Revenue and Market Share by Application (2020-2025)
2.5.3 Global Contraceptive Drugs and Devices Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Contraceptive Drugs and Devices Breakdown Data by Company
3.1.1 Global Contraceptive Drugs and Devices Annual Sales by Company (2020-2025)
3.1.2 Global Contraceptive Drugs and Devices Sales Market Share by Company (2020-2025)
3.2 Global Contraceptive Drugs and Devices Annual Revenue by Company (2020-2025)
3.2.1 Global Contraceptive Drugs and Devices Revenue by Company (2020-2025)
3.2.2 Global Contraceptive Drugs and Devices Revenue Market Share by Company (2020-2025)
3.3 Global Contraceptive Drugs and Devices Sale Price by Company
3.4 Key Manufacturers Contraceptive Drugs and Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Contraceptive Drugs and Devices Product Location Distribution
3.4.2 Players Contraceptive Drugs and Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CONTRACEPTIVE DRUGS AND DEVICES BY GEOGRAPHIC REGION
4.1 World Historic Contraceptive Drugs and Devices Market Size by Geographic Region (2020-2025)
4.1.1 Global Contraceptive Drugs and Devices Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Contraceptive Drugs and Devices Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Contraceptive Drugs and Devices Market Size by Country/Region (2020-2025)
4.2.1 Global Contraceptive Drugs and Devices Annual Sales by Country/Region (2020-2025)
4.2.2 Global Contraceptive Drugs and Devices Annual Revenue by Country/Region (2020-2025)
4.3 Americas Contraceptive Drugs and Devices Sales Growth
4.4 APAC Contraceptive Drugs and Devices Sales Growth
4.5 Europe Contraceptive Drugs and Devices Sales Growth
4.6 Middle East & Africa Contraceptive Drugs and Devices Sales Growth
5 AMERICAS
5.1 Americas Contraceptive Drugs and Devices Sales by Country
5.1.1 Americas Contraceptive Drugs and Devices Sales by Country (2020-2025)
5.1.2 Americas Contraceptive Drugs and Devices Revenue by Country (2020-2025)
5.2 Americas Contraceptive Drugs and Devices Sales by Type (2020-2025)
5.3 Americas Contraceptive Drugs and Devices Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Contraceptive Drugs and Devices Sales by Region
6.1.1 APAC Contraceptive Drugs and Devices Sales by Region (2020-2025)
6.1.2 APAC Contraceptive Drugs and Devices Revenue by Region (2020-2025)
6.2 APAC Contraceptive Drugs and Devices Sales by Type (2020-2025)
6.3 APAC Contraceptive Drugs and Devices Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Contraceptive Drugs and Devices by Country
7.1.1 Europe Contraceptive Drugs and Devices Sales by Country (2020-2025)
7.1.2 Europe Contraceptive Drugs and Devices Revenue by Country (2020-2025)
7.2 Europe Contraceptive Drugs and Devices Sales by Type (2020-2025)
7.3 Europe Contraceptive Drugs and Devices Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Contraceptive Drugs and Devices by Country
8.1.1 Middle East & Africa Contraceptive Drugs and Devices Sales by Country (2020-2025)
8.1.2 Middle East & Africa Contraceptive Drugs and Devices Revenue by Country (2020-2025)
8.2 Middle East & Africa Contraceptive Drugs and Devices Sales by Type (2020-2025)
8.3 Middle East & Africa Contraceptive Drugs and Devices Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Contraceptive Drugs and Devices
10.3 Manufacturing Process Analysis of Contraceptive Drugs and Devices
10.4 Industry Chain Structure of Contraceptive Drugs and Devices
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Contraceptive Drugs and Devices Distributors
11.3 Contraceptive Drugs and Devices Customer
12 WORLD FORECAST REVIEW FOR CONTRACEPTIVE DRUGS AND DEVICES BY GEOGRAPHIC REGION
12.1 Global Contraceptive Drugs and Devices Market Size Forecast by Region
12.1.1 Global Contraceptive Drugs and Devices Forecast by Region (2026-2031)
12.1.2 Global Contraceptive Drugs and Devices Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Contraceptive Drugs and Devices Forecast by Type (2026-2031)
12.7 Global Contraceptive Drugs and Devices Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bayer Healthcare
13.1.1 Bayer Healthcare Company Information
13.1.2 Bayer Healthcare Contraceptive Drugs and Devices Product Portfolios and Specifications
13.1.3 Bayer Healthcare Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bayer Healthcare Main Business Overview
13.1.5 Bayer Healthcare Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Contraceptive Drugs and Devices Product Portfolios and Specifications
13.2.3 Merck Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Church & Dwight
13.3.1 Church & Dwight Company Information
13.3.2 Church & Dwight Contraceptive Drugs and Devices Product Portfolios and Specifications
13.3.3 Church & Dwight Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Church & Dwight Main Business Overview
13.3.5 Church & Dwight Latest Developments
13.4 Warmer Chilcott
13.4.1 Warmer Chilcott Company Information
13.4.2 Warmer Chilcott Contraceptive Drugs and Devices Product Portfolios and Specifications
13.4.3 Warmer Chilcott Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Warmer Chilcott Main Business Overview
13.4.5 Warmer Chilcott Latest Developments
13.5 Agile Therapeutics
13.5.1 Agile Therapeutics Company Information
13.5.2 Agile Therapeutics Contraceptive Drugs and Devices Product Portfolios and Specifications
13.5.3 Agile Therapeutics Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Agile Therapeutics Main Business Overview
13.5.5 Agile Therapeutics Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Contraceptive Drugs and Devices Product Portfolios and Specifications
13.6.3 Pfizer Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 BioSante Pharmaceuticals
13.7.1 BioSante Pharmaceuticals Company Information
13.7.2 BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Portfolios and Specifications
13.7.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 BioSante Pharmaceuticals Main Business Overview
13.7.5 BioSante Pharmaceuticals Latest Developments
13.8 Mayer Laboratories
13.8.1 Mayer Laboratories Company Information
13.8.2 Mayer Laboratories Contraceptive Drugs and Devices Product Portfolios and Specifications
13.8.3 Mayer Laboratories Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Mayer Laboratories Main Business Overview
13.8.5 Mayer Laboratories Latest Developments
13.9 Pantarhei Bioscience
13.9.1 Pantarhei Bioscience Company Information
13.9.2 Pantarhei Bioscience Contraceptive Drugs and Devices Product Portfolios and Specifications
13.9.3 Pantarhei Bioscience Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Pantarhei Bioscience Main Business Overview
13.9.5 Pantarhei Bioscience Latest Developments
13.10 Teva Pharmaceutical Industries
13.10.1 Teva Pharmaceutical Industries Company Information
13.10.2 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Portfolios and Specifications
13.10.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Teva Pharmaceutical Industries Main Business Overview
13.10.5 Teva Pharmaceutical Industries Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Contraceptive Drugs and Devices Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Contraceptive Drugs and Devices by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Contraceptive Drugs and Devices by Country/Region, 2020, 2024 & 2031
2.2 Contraceptive Drugs and Devices Segment by Type
2.2.1 Oral
2.2.2 Vaginal
2.2.3 Injectable Contraceptive Drugs
2.2.4 Male/Female Contraceptive Devices
2.3 Contraceptive Drugs and Devices Sales by Type
2.3.1 Global Contraceptive Drugs and Devices Sales Market Share by Type (2020-2025)
2.3.2 Global Contraceptive Drugs and Devices Revenue and Market Share by Type (2020-2025)
2.3.3 Global Contraceptive Drugs and Devices Sale Price by Type (2020-2025)
2.4 Contraceptive Drugs and Devices Segment by Application
2.4.1 Hospitals
2.4.2 Pharmacies
2.4.3 Others
2.5 Contraceptive Drugs and Devices Sales by Application
2.5.1 Global Contraceptive Drugs and Devices Sale Market Share by Application (2020-2025)
2.5.2 Global Contraceptive Drugs and Devices Revenue and Market Share by Application (2020-2025)
2.5.3 Global Contraceptive Drugs and Devices Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Contraceptive Drugs and Devices Breakdown Data by Company
3.1.1 Global Contraceptive Drugs and Devices Annual Sales by Company (2020-2025)
3.1.2 Global Contraceptive Drugs and Devices Sales Market Share by Company (2020-2025)
3.2 Global Contraceptive Drugs and Devices Annual Revenue by Company (2020-2025)
3.2.1 Global Contraceptive Drugs and Devices Revenue by Company (2020-2025)
3.2.2 Global Contraceptive Drugs and Devices Revenue Market Share by Company (2020-2025)
3.3 Global Contraceptive Drugs and Devices Sale Price by Company
3.4 Key Manufacturers Contraceptive Drugs and Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Contraceptive Drugs and Devices Product Location Distribution
3.4.2 Players Contraceptive Drugs and Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CONTRACEPTIVE DRUGS AND DEVICES BY GEOGRAPHIC REGION
4.1 World Historic Contraceptive Drugs and Devices Market Size by Geographic Region (2020-2025)
4.1.1 Global Contraceptive Drugs and Devices Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Contraceptive Drugs and Devices Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Contraceptive Drugs and Devices Market Size by Country/Region (2020-2025)
4.2.1 Global Contraceptive Drugs and Devices Annual Sales by Country/Region (2020-2025)
4.2.2 Global Contraceptive Drugs and Devices Annual Revenue by Country/Region (2020-2025)
4.3 Americas Contraceptive Drugs and Devices Sales Growth
4.4 APAC Contraceptive Drugs and Devices Sales Growth
4.5 Europe Contraceptive Drugs and Devices Sales Growth
4.6 Middle East & Africa Contraceptive Drugs and Devices Sales Growth
5 AMERICAS
5.1 Americas Contraceptive Drugs and Devices Sales by Country
5.1.1 Americas Contraceptive Drugs and Devices Sales by Country (2020-2025)
5.1.2 Americas Contraceptive Drugs and Devices Revenue by Country (2020-2025)
5.2 Americas Contraceptive Drugs and Devices Sales by Type (2020-2025)
5.3 Americas Contraceptive Drugs and Devices Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Contraceptive Drugs and Devices Sales by Region
6.1.1 APAC Contraceptive Drugs and Devices Sales by Region (2020-2025)
6.1.2 APAC Contraceptive Drugs and Devices Revenue by Region (2020-2025)
6.2 APAC Contraceptive Drugs and Devices Sales by Type (2020-2025)
6.3 APAC Contraceptive Drugs and Devices Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Contraceptive Drugs and Devices by Country
7.1.1 Europe Contraceptive Drugs and Devices Sales by Country (2020-2025)
7.1.2 Europe Contraceptive Drugs and Devices Revenue by Country (2020-2025)
7.2 Europe Contraceptive Drugs and Devices Sales by Type (2020-2025)
7.3 Europe Contraceptive Drugs and Devices Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Contraceptive Drugs and Devices by Country
8.1.1 Middle East & Africa Contraceptive Drugs and Devices Sales by Country (2020-2025)
8.1.2 Middle East & Africa Contraceptive Drugs and Devices Revenue by Country (2020-2025)
8.2 Middle East & Africa Contraceptive Drugs and Devices Sales by Type (2020-2025)
8.3 Middle East & Africa Contraceptive Drugs and Devices Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Contraceptive Drugs and Devices
10.3 Manufacturing Process Analysis of Contraceptive Drugs and Devices
10.4 Industry Chain Structure of Contraceptive Drugs and Devices
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Contraceptive Drugs and Devices Distributors
11.3 Contraceptive Drugs and Devices Customer
12 WORLD FORECAST REVIEW FOR CONTRACEPTIVE DRUGS AND DEVICES BY GEOGRAPHIC REGION
12.1 Global Contraceptive Drugs and Devices Market Size Forecast by Region
12.1.1 Global Contraceptive Drugs and Devices Forecast by Region (2026-2031)
12.1.2 Global Contraceptive Drugs and Devices Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Contraceptive Drugs and Devices Forecast by Type (2026-2031)
12.7 Global Contraceptive Drugs and Devices Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bayer Healthcare
13.1.1 Bayer Healthcare Company Information
13.1.2 Bayer Healthcare Contraceptive Drugs and Devices Product Portfolios and Specifications
13.1.3 Bayer Healthcare Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bayer Healthcare Main Business Overview
13.1.5 Bayer Healthcare Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Contraceptive Drugs and Devices Product Portfolios and Specifications
13.2.3 Merck Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Church & Dwight
13.3.1 Church & Dwight Company Information
13.3.2 Church & Dwight Contraceptive Drugs and Devices Product Portfolios and Specifications
13.3.3 Church & Dwight Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Church & Dwight Main Business Overview
13.3.5 Church & Dwight Latest Developments
13.4 Warmer Chilcott
13.4.1 Warmer Chilcott Company Information
13.4.2 Warmer Chilcott Contraceptive Drugs and Devices Product Portfolios and Specifications
13.4.3 Warmer Chilcott Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Warmer Chilcott Main Business Overview
13.4.5 Warmer Chilcott Latest Developments
13.5 Agile Therapeutics
13.5.1 Agile Therapeutics Company Information
13.5.2 Agile Therapeutics Contraceptive Drugs and Devices Product Portfolios and Specifications
13.5.3 Agile Therapeutics Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Agile Therapeutics Main Business Overview
13.5.5 Agile Therapeutics Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Contraceptive Drugs and Devices Product Portfolios and Specifications
13.6.3 Pfizer Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 BioSante Pharmaceuticals
13.7.1 BioSante Pharmaceuticals Company Information
13.7.2 BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Portfolios and Specifications
13.7.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 BioSante Pharmaceuticals Main Business Overview
13.7.5 BioSante Pharmaceuticals Latest Developments
13.8 Mayer Laboratories
13.8.1 Mayer Laboratories Company Information
13.8.2 Mayer Laboratories Contraceptive Drugs and Devices Product Portfolios and Specifications
13.8.3 Mayer Laboratories Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Mayer Laboratories Main Business Overview
13.8.5 Mayer Laboratories Latest Developments
13.9 Pantarhei Bioscience
13.9.1 Pantarhei Bioscience Company Information
13.9.2 Pantarhei Bioscience Contraceptive Drugs and Devices Product Portfolios and Specifications
13.9.3 Pantarhei Bioscience Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Pantarhei Bioscience Main Business Overview
13.9.5 Pantarhei Bioscience Latest Developments
13.10 Teva Pharmaceutical Industries
13.10.1 Teva Pharmaceutical Industries Company Information
13.10.2 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Portfolios and Specifications
13.10.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Teva Pharmaceutical Industries Main Business Overview
13.10.5 Teva Pharmaceutical Industries Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Contraceptive Drugs and Devices Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Contraceptive Drugs and Devices Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Vaginal
Table 5. Major Players of Injectable Contraceptive Drugs
Table 6. Major Players of Male/Female Contraceptive Devices
Table 7. Global Contraceptive Drugs and Devices Sales by Type (2020-2025) & (K Units)
Table 8. Global Contraceptive Drugs and Devices Sales Market Share by Type (2020-2025)
Table 9. Global Contraceptive Drugs and Devices Revenue by Type (2020-2025) & ($ million)
Table 10. Global Contraceptive Drugs and Devices Revenue Market Share by Type (2020-2025)
Table 11. Global Contraceptive Drugs and Devices Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Contraceptive Drugs and Devices Sale by Application (2020-2025) & (K Units)
Table 13. Global Contraceptive Drugs and Devices Sale Market Share by Application (2020-2025)
Table 14. Global Contraceptive Drugs and Devices Revenue by Application (2020-2025) & ($ million)
Table 15. Global Contraceptive Drugs and Devices Revenue Market Share by Application (2020-2025)
Table 16. Global Contraceptive Drugs and Devices Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Contraceptive Drugs and Devices Sales by Company (2020-2025) & (K Units)
Table 18. Global Contraceptive Drugs and Devices Sales Market Share by Company (2020-2025)
Table 19. Global Contraceptive Drugs and Devices Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Contraceptive Drugs and Devices Revenue Market Share by Company (2020-2025)
Table 21. Global Contraceptive Drugs and Devices Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Contraceptive Drugs and Devices Producing Area Distribution and Sales Area
Table 23. Players Contraceptive Drugs and Devices Products Offered
Table 24. Contraceptive Drugs and Devices Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Contraceptive Drugs and Devices Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Contraceptive Drugs and Devices Sales Market Share Geographic Region (2020-2025)
Table 29. Global Contraceptive Drugs and Devices Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Contraceptive Drugs and Devices Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Contraceptive Drugs and Devices Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Contraceptive Drugs and Devices Sales Market Share by Country/Region (2020-2025)
Table 33. Global Contraceptive Drugs and Devices Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Contraceptive Drugs and Devices Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Contraceptive Drugs and Devices Sales by Country (2020-2025) & (K Units)
Table 36. Americas Contraceptive Drugs and Devices Sales Market Share by Country (2020-2025)
Table 37. Americas Contraceptive Drugs and Devices Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Contraceptive Drugs and Devices Sales by Type (2020-2025) & (K Units)
Table 39. Americas Contraceptive Drugs and Devices Sales by Application (2020-2025) & (K Units)
Table 40. APAC Contraceptive Drugs and Devices Sales by Region (2020-2025) & (K Units)
Table 41. APAC Contraceptive Drugs and Devices Sales Market Share by Region (2020-2025)
Table 42. APAC Contraceptive Drugs and Devices Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Contraceptive Drugs and Devices Sales by Type (2020-2025) & (K Units)
Table 44. APAC Contraceptive Drugs and Devices Sales by Application (2020-2025) & (K Units)
Table 45. Europe Contraceptive Drugs and Devices Sales by Country (2020-2025) & (K Units)
Table 46. Europe Contraceptive Drugs and Devices Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Contraceptive Drugs and Devices Sales by Type (2020-2025) & (K Units)
Table 48. Europe Contraceptive Drugs and Devices Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Contraceptive Drugs and Devices Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Contraceptive Drugs and Devices Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Contraceptive Drugs and Devices Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Contraceptive Drugs and Devices Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Contraceptive Drugs and Devices
Table 54. Key Market Challenges & Risks of Contraceptive Drugs and Devices
Table 55. Key Industry Trends of Contraceptive Drugs and Devices
Table 56. Contraceptive Drugs and Devices Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Contraceptive Drugs and Devices Distributors List
Table 59. Contraceptive Drugs and Devices Customer List
Table 60. Global Contraceptive Drugs and Devices Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Contraceptive Drugs and Devices Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Contraceptive Drugs and Devices Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Contraceptive Drugs and Devices Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Contraceptive Drugs and Devices Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Contraceptive Drugs and Devices Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Contraceptive Drugs and Devices Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Contraceptive Drugs and Devices Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Contraceptive Drugs and Devices Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Contraceptive Drugs and Devices Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Contraceptive Drugs and Devices Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Contraceptive Drugs and Devices Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Contraceptive Drugs and Devices Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Contraceptive Drugs and Devices Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Bayer Healthcare Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 75. Bayer Healthcare Contraceptive Drugs and Devices Product Portfolios and Specifications
Table 76. Bayer Healthcare Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Bayer Healthcare Main Business
Table 78. Bayer Healthcare Latest Developments
Table 79. Merck Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Contraceptive Drugs and Devices Product Portfolios and Specifications
Table 81. Merck Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Church & Dwight Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 85. Church & Dwight Contraceptive Drugs and Devices Product Portfolios and Specifications
Table 86. Church & Dwight Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Church & Dwight Main Business
Table 88. Church & Dwight Latest Developments
Table 89. Warmer Chilcott Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 90. Warmer Chilcott Contraceptive Drugs and Devices Product Portfolios and Specifications
Table 91. Warmer Chilcott Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Warmer Chilcott Main Business
Table 93. Warmer Chilcott Latest Developments
Table 94. Agile Therapeutics Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 95. Agile Therapeutics Contraceptive Drugs and Devices Product Portfolios and Specifications
Table 96. Agile Therapeutics Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Agile Therapeutics Main Business
Table 98. Agile Therapeutics Latest Developments
Table 99. Pfizer Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 100. Pfizer Contraceptive Drugs and Devices Product Portfolios and Specifications
Table 101. Pfizer Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Pfizer Main Business
Table 103. Pfizer Latest Developments
Table 104. BioSante Pharmaceuticals Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 105. BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Portfolios and Specifications
Table 106. BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. BioSante Pharmaceuticals Main Business
Table 108. BioSante Pharmaceuticals Latest Developments
Table 109. Mayer Laboratories Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 110. Mayer Laboratories Contraceptive Drugs and Devices Product Portfolios and Specifications
Table 111. Mayer Laboratories Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Mayer Laboratories Main Business
Table 113. Mayer Laboratories Latest Developments
Table 114. Pantarhei Bioscience Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 115. Pantarhei Bioscience Contraceptive Drugs and Devices Product Portfolios and Specifications
Table 116. Pantarhei Bioscience Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Pantarhei Bioscience Main Business
Table 118. Pantarhei Bioscience Latest Developments
Table 119. Teva Pharmaceutical Industries Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 120. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Portfolios and Specifications
Table 121. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Teva Pharmaceutical Industries Main Business
Table 123. Teva Pharmaceutical Industries Latest Developments
Table 1. Contraceptive Drugs and Devices Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Contraceptive Drugs and Devices Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Vaginal
Table 5. Major Players of Injectable Contraceptive Drugs
Table 6. Major Players of Male/Female Contraceptive Devices
Table 7. Global Contraceptive Drugs and Devices Sales by Type (2020-2025) & (K Units)
Table 8. Global Contraceptive Drugs and Devices Sales Market Share by Type (2020-2025)
Table 9. Global Contraceptive Drugs and Devices Revenue by Type (2020-2025) & ($ million)
Table 10. Global Contraceptive Drugs and Devices Revenue Market Share by Type (2020-2025)
Table 11. Global Contraceptive Drugs and Devices Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Contraceptive Drugs and Devices Sale by Application (2020-2025) & (K Units)
Table 13. Global Contraceptive Drugs and Devices Sale Market Share by Application (2020-2025)
Table 14. Global Contraceptive Drugs and Devices Revenue by Application (2020-2025) & ($ million)
Table 15. Global Contraceptive Drugs and Devices Revenue Market Share by Application (2020-2025)
Table 16. Global Contraceptive Drugs and Devices Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Contraceptive Drugs and Devices Sales by Company (2020-2025) & (K Units)
Table 18. Global Contraceptive Drugs and Devices Sales Market Share by Company (2020-2025)
Table 19. Global Contraceptive Drugs and Devices Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Contraceptive Drugs and Devices Revenue Market Share by Company (2020-2025)
Table 21. Global Contraceptive Drugs and Devices Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Contraceptive Drugs and Devices Producing Area Distribution and Sales Area
Table 23. Players Contraceptive Drugs and Devices Products Offered
Table 24. Contraceptive Drugs and Devices Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Contraceptive Drugs and Devices Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Contraceptive Drugs and Devices Sales Market Share Geographic Region (2020-2025)
Table 29. Global Contraceptive Drugs and Devices Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Contraceptive Drugs and Devices Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Contraceptive Drugs and Devices Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Contraceptive Drugs and Devices Sales Market Share by Country/Region (2020-2025)
Table 33. Global Contraceptive Drugs and Devices Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Contraceptive Drugs and Devices Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Contraceptive Drugs and Devices Sales by Country (2020-2025) & (K Units)
Table 36. Americas Contraceptive Drugs and Devices Sales Market Share by Country (2020-2025)
Table 37. Americas Contraceptive Drugs and Devices Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Contraceptive Drugs and Devices Sales by Type (2020-2025) & (K Units)
Table 39. Americas Contraceptive Drugs and Devices Sales by Application (2020-2025) & (K Units)
Table 40. APAC Contraceptive Drugs and Devices Sales by Region (2020-2025) & (K Units)
Table 41. APAC Contraceptive Drugs and Devices Sales Market Share by Region (2020-2025)
Table 42. APAC Contraceptive Drugs and Devices Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Contraceptive Drugs and Devices Sales by Type (2020-2025) & (K Units)
Table 44. APAC Contraceptive Drugs and Devices Sales by Application (2020-2025) & (K Units)
Table 45. Europe Contraceptive Drugs and Devices Sales by Country (2020-2025) & (K Units)
Table 46. Europe Contraceptive Drugs and Devices Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Contraceptive Drugs and Devices Sales by Type (2020-2025) & (K Units)
Table 48. Europe Contraceptive Drugs and Devices Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Contraceptive Drugs and Devices Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Contraceptive Drugs and Devices Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Contraceptive Drugs and Devices Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Contraceptive Drugs and Devices Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Contraceptive Drugs and Devices
Table 54. Key Market Challenges & Risks of Contraceptive Drugs and Devices
Table 55. Key Industry Trends of Contraceptive Drugs and Devices
Table 56. Contraceptive Drugs and Devices Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Contraceptive Drugs and Devices Distributors List
Table 59. Contraceptive Drugs and Devices Customer List
Table 60. Global Contraceptive Drugs and Devices Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Contraceptive Drugs and Devices Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Contraceptive Drugs and Devices Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Contraceptive Drugs and Devices Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Contraceptive Drugs and Devices Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Contraceptive Drugs and Devices Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Contraceptive Drugs and Devices Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Contraceptive Drugs and Devices Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Contraceptive Drugs and Devices Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Contraceptive Drugs and Devices Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Contraceptive Drugs and Devices Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Contraceptive Drugs and Devices Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Contraceptive Drugs and Devices Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Contraceptive Drugs and Devices Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Bayer Healthcare Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 75. Bayer Healthcare Contraceptive Drugs and Devices Product Portfolios and Specifications
Table 76. Bayer Healthcare Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Bayer Healthcare Main Business
Table 78. Bayer Healthcare Latest Developments
Table 79. Merck Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Contraceptive Drugs and Devices Product Portfolios and Specifications
Table 81. Merck Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Church & Dwight Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 85. Church & Dwight Contraceptive Drugs and Devices Product Portfolios and Specifications
Table 86. Church & Dwight Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Church & Dwight Main Business
Table 88. Church & Dwight Latest Developments
Table 89. Warmer Chilcott Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 90. Warmer Chilcott Contraceptive Drugs and Devices Product Portfolios and Specifications
Table 91. Warmer Chilcott Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Warmer Chilcott Main Business
Table 93. Warmer Chilcott Latest Developments
Table 94. Agile Therapeutics Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 95. Agile Therapeutics Contraceptive Drugs and Devices Product Portfolios and Specifications
Table 96. Agile Therapeutics Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Agile Therapeutics Main Business
Table 98. Agile Therapeutics Latest Developments
Table 99. Pfizer Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 100. Pfizer Contraceptive Drugs and Devices Product Portfolios and Specifications
Table 101. Pfizer Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Pfizer Main Business
Table 103. Pfizer Latest Developments
Table 104. BioSante Pharmaceuticals Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 105. BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Portfolios and Specifications
Table 106. BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. BioSante Pharmaceuticals Main Business
Table 108. BioSante Pharmaceuticals Latest Developments
Table 109. Mayer Laboratories Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 110. Mayer Laboratories Contraceptive Drugs and Devices Product Portfolios and Specifications
Table 111. Mayer Laboratories Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Mayer Laboratories Main Business
Table 113. Mayer Laboratories Latest Developments
Table 114. Pantarhei Bioscience Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 115. Pantarhei Bioscience Contraceptive Drugs and Devices Product Portfolios and Specifications
Table 116. Pantarhei Bioscience Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Pantarhei Bioscience Main Business
Table 118. Pantarhei Bioscience Latest Developments
Table 119. Teva Pharmaceutical Industries Basic Information, Contraceptive Drugs and Devices Manufacturing Base, Sales Area and Its Competitors
Table 120. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Portfolios and Specifications
Table 121. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Teva Pharmaceutical Industries Main Business
Table 123. Teva Pharmaceutical Industries Latest Developments
LIST OF FIGURES
Figure 1. Picture of Contraceptive Drugs and Devices
Figure 2. Contraceptive Drugs and Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Contraceptive Drugs and Devices Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Contraceptive Drugs and Devices Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Contraceptive Drugs and Devices Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Contraceptive Drugs and Devices Sales Market Share by Country/Region (2024)
Figure 10. Contraceptive Drugs and Devices Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Vaginal
Figure 13. Product Picture of Injectable Contraceptive Drugs
Figure 14. Product Picture of Male/Female Contraceptive Devices
Figure 15. Global Contraceptive Drugs and Devices Sales Market Share by Type in 2025
Figure 16. Global Contraceptive Drugs and Devices Revenue Market Share by Type (2020-2025)
Figure 17. Contraceptive Drugs and Devices Consumed in Hospitals
Figure 18. Global Contraceptive Drugs and Devices Market: Hospitals (2020-2025) & (K Units)
Figure 19. Contraceptive Drugs and Devices Consumed in Pharmacies
Figure 20. Global Contraceptive Drugs and Devices Market: Pharmacies (2020-2025) & (K Units)
Figure 21. Contraceptive Drugs and Devices Consumed in Others
Figure 22. Global Contraceptive Drugs and Devices Market: Others (2020-2025) & (K Units)
Figure 23. Global Contraceptive Drugs and Devices Sale Market Share by Application (2024)
Figure 24. Global Contraceptive Drugs and Devices Revenue Market Share by Application in 2025
Figure 25. Contraceptive Drugs and Devices Sales by Company in 2025 (K Units)
Figure 26. Global Contraceptive Drugs and Devices Sales Market Share by Company in 2025
Figure 27. Contraceptive Drugs and Devices Revenue by Company in 2025 ($ millions)
Figure 28. Global Contraceptive Drugs and Devices Revenue Market Share by Company in 2025
Figure 29. Global Contraceptive Drugs and Devices Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Contraceptive Drugs and Devices Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Contraceptive Drugs and Devices Sales 2020-2025 (K Units)
Figure 32. Americas Contraceptive Drugs and Devices Revenue 2020-2025 ($ millions)
Figure 33. APAC Contraceptive Drugs and Devices Sales 2020-2025 (K Units)
Figure 34. APAC Contraceptive Drugs and Devices Revenue 2020-2025 ($ millions)
Figure 35. Europe Contraceptive Drugs and Devices Sales 2020-2025 (K Units)
Figure 36. Europe Contraceptive Drugs and Devices Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Contraceptive Drugs and Devices Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Contraceptive Drugs and Devices Revenue 2020-2025 ($ millions)
Figure 39. Americas Contraceptive Drugs and Devices Sales Market Share by Country in 2025
Figure 40. Americas Contraceptive Drugs and Devices Revenue Market Share by Country (2020-2025)
Figure 41. Americas Contraceptive Drugs and Devices Sales Market Share by Type (2020-2025)
Figure 42. Americas Contraceptive Drugs and Devices Sales Market Share by Application (2020-2025)
Figure 43. United States Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Contraceptive Drugs and Devices Sales Market Share by Region in 2025
Figure 48. APAC Contraceptive Drugs and Devices Revenue Market Share by Region (2020-2025)
Figure 49. APAC Contraceptive Drugs and Devices Sales Market Share by Type (2020-2025)
Figure 50. APAC Contraceptive Drugs and Devices Sales Market Share by Application (2020-2025)
Figure 51. China Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 55. India Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Contraceptive Drugs and Devices Sales Market Share by Country in 2025
Figure 59. Europe Contraceptive Drugs and Devices Revenue Market Share by Country (2020-2025)
Figure 60. Europe Contraceptive Drugs and Devices Sales Market Share by Type (2020-2025)
Figure 61. Europe Contraceptive Drugs and Devices Sales Market Share by Application (2020-2025)
Figure 62. Germany Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 63. France Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Contraceptive Drugs and Devices Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Contraceptive Drugs and Devices Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Contraceptive Drugs and Devices Sales Market Share by Application (2020-2025)
Figure 70. Egypt Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Contraceptive Drugs and Devices in 2025
Figure 76. Manufacturing Process Analysis of Contraceptive Drugs and Devices
Figure 77. Industry Chain Structure of Contraceptive Drugs and Devices
Figure 78. Channels of Distribution
Figure 79. Global Contraceptive Drugs and Devices Sales Market Forecast by Region (2026-2031)
Figure 80. Global Contraceptive Drugs and Devices Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Contraceptive Drugs and Devices Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Contraceptive Drugs and Devices Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Contraceptive Drugs and Devices Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Contraceptive Drugs and Devices Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Contraceptive Drugs and Devices
Figure 2. Contraceptive Drugs and Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Contraceptive Drugs and Devices Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Contraceptive Drugs and Devices Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Contraceptive Drugs and Devices Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Contraceptive Drugs and Devices Sales Market Share by Country/Region (2024)
Figure 10. Contraceptive Drugs and Devices Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Vaginal
Figure 13. Product Picture of Injectable Contraceptive Drugs
Figure 14. Product Picture of Male/Female Contraceptive Devices
Figure 15. Global Contraceptive Drugs and Devices Sales Market Share by Type in 2025
Figure 16. Global Contraceptive Drugs and Devices Revenue Market Share by Type (2020-2025)
Figure 17. Contraceptive Drugs and Devices Consumed in Hospitals
Figure 18. Global Contraceptive Drugs and Devices Market: Hospitals (2020-2025) & (K Units)
Figure 19. Contraceptive Drugs and Devices Consumed in Pharmacies
Figure 20. Global Contraceptive Drugs and Devices Market: Pharmacies (2020-2025) & (K Units)
Figure 21. Contraceptive Drugs and Devices Consumed in Others
Figure 22. Global Contraceptive Drugs and Devices Market: Others (2020-2025) & (K Units)
Figure 23. Global Contraceptive Drugs and Devices Sale Market Share by Application (2024)
Figure 24. Global Contraceptive Drugs and Devices Revenue Market Share by Application in 2025
Figure 25. Contraceptive Drugs and Devices Sales by Company in 2025 (K Units)
Figure 26. Global Contraceptive Drugs and Devices Sales Market Share by Company in 2025
Figure 27. Contraceptive Drugs and Devices Revenue by Company in 2025 ($ millions)
Figure 28. Global Contraceptive Drugs and Devices Revenue Market Share by Company in 2025
Figure 29. Global Contraceptive Drugs and Devices Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Contraceptive Drugs and Devices Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Contraceptive Drugs and Devices Sales 2020-2025 (K Units)
Figure 32. Americas Contraceptive Drugs and Devices Revenue 2020-2025 ($ millions)
Figure 33. APAC Contraceptive Drugs and Devices Sales 2020-2025 (K Units)
Figure 34. APAC Contraceptive Drugs and Devices Revenue 2020-2025 ($ millions)
Figure 35. Europe Contraceptive Drugs and Devices Sales 2020-2025 (K Units)
Figure 36. Europe Contraceptive Drugs and Devices Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Contraceptive Drugs and Devices Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Contraceptive Drugs and Devices Revenue 2020-2025 ($ millions)
Figure 39. Americas Contraceptive Drugs and Devices Sales Market Share by Country in 2025
Figure 40. Americas Contraceptive Drugs and Devices Revenue Market Share by Country (2020-2025)
Figure 41. Americas Contraceptive Drugs and Devices Sales Market Share by Type (2020-2025)
Figure 42. Americas Contraceptive Drugs and Devices Sales Market Share by Application (2020-2025)
Figure 43. United States Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Contraceptive Drugs and Devices Sales Market Share by Region in 2025
Figure 48. APAC Contraceptive Drugs and Devices Revenue Market Share by Region (2020-2025)
Figure 49. APAC Contraceptive Drugs and Devices Sales Market Share by Type (2020-2025)
Figure 50. APAC Contraceptive Drugs and Devices Sales Market Share by Application (2020-2025)
Figure 51. China Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 55. India Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Contraceptive Drugs and Devices Sales Market Share by Country in 2025
Figure 59. Europe Contraceptive Drugs and Devices Revenue Market Share by Country (2020-2025)
Figure 60. Europe Contraceptive Drugs and Devices Sales Market Share by Type (2020-2025)
Figure 61. Europe Contraceptive Drugs and Devices Sales Market Share by Application (2020-2025)
Figure 62. Germany Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 63. France Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Contraceptive Drugs and Devices Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Contraceptive Drugs and Devices Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Contraceptive Drugs and Devices Sales Market Share by Application (2020-2025)
Figure 70. Egypt Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Contraceptive Drugs and Devices Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Contraceptive Drugs and Devices in 2025
Figure 76. Manufacturing Process Analysis of Contraceptive Drugs and Devices
Figure 77. Industry Chain Structure of Contraceptive Drugs and Devices
Figure 78. Channels of Distribution
Figure 79. Global Contraceptive Drugs and Devices Sales Market Forecast by Region (2026-2031)
Figure 80. Global Contraceptive Drugs and Devices Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Contraceptive Drugs and Devices Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Contraceptive Drugs and Devices Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Contraceptive Drugs and Devices Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Contraceptive Drugs and Devices Revenue Market Share Forecast by Application (2026-2031)
